DHAKAINS: Credit Rating Result21 Jan 2026
National Credit Ratings Limited (NCR) has assigned the surveillance entity rating of the Company as "AA+" in the long term and "ST-1" in the short term along with Developing outlook based on audited financial statements as on December 31, 2024.
DHAKAINS: Share Transmission of Deceased Sponsor Director among Successors18 Nov 2025
The Company has informed that 20,06,250 shares of Late Fazlur Rahman, former Sponsor Director of the company who passed away on 25.12.2023, will be transmitted among his successors according to the Succession Certificate issued by the Honorable Court. (cont.)
DHAKAINS: Q3 Financials02 Nov 2025
(Q3 Un-audited): EPS was Tk. 0.45 for July-September, 2025 as against Tk. 0.58 for July-September, 2024; EPS was Tk. 1.68 for January-September, 2025 as against Tk. 2.08 for January-September, 2024. NOCFPS was Tk. (0.36) for January-September, 2025 as against Tk. 0.63 for January-September, 2024. NAV per share was Tk. 36.86 (with revaluation) and Tk. 26.22 (without revaluation) as on September 30, 2025 and Tk. 35.65 (with revaluation) and Tk. 25.02 (without revaluation) as on December 31, 2024.
DHAKAINS: Board Meeting schedule under LR 16(1)27 Oct 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.
DHAKAINS: Dividend Disbursement15 Sept 2025
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.
DHAKAINS: Q2 Financials03 Aug 2025
(Q2 Un-audited): EPS was Tk. 0.73 for April-June 2025 as against Tk. 0.75 for April-June 2024; EPS was Tk. 1.23 for January-June 2025 as against Tk. 1.50 for January-June 2024. NOCFPS was Tk. (0.54) for January-June 2025 as against Tk. 0.75 for January-June 2024. NAV per share (with revaluation) was Tk. 36.94 as on June 30, 2025 and Tk. 35.65 as on December 31, 2024. NAV per share (without revaluation) was Tk. 26.31 as on June 30, 2025 and Tk. 25.02 as on December 31, 2024.
DHAKAINS: Board Meeting schedule under LR 16(1)28 Jul 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 31, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025
DHAKAINS: Resumption after Record Date10 Jul 2025
Trading of the shares of the company will resume on 13.07.2025.
DHAKAINS: Suspension for Record Date09 Jul 2025
Trading of the shares of the company will remain suspended on record date i.e., 10.07.2025.
DHAKAINS: Spot News07 Jul 2025
Trading of the shares will be allowed only in the Spot Market and block transactions will be settled as per the spot settlement cycle with cum benefit from 08.07.2025 to 09.07.2025, and trading of the shares will remain suspended on record date i.e., 10.07.2025.
DHAKAINS: Qualified Opinion and Emphasis of Matter23 Jun 2025
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended December 31, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/DHAKAINS_2024.pdf
DHAKAINS: Dividend Declaration03 Jun 2025
The Board of Directors has recommended 10% Cash Dividend for the year ended December 31, 2024. Date of AGM: 07.08.2025, Time: 11:00 AM, Venue: Digital Platform. Record Date: 10.07.2025. The Company has also reported EPS of Tk. 2.41, NAV per share with revaluation of Tk. 35.65, NAV per share without revaluation of Tk. 25.02 and NOCFPS of Tk. 0.84 for the year ended December 31, 2024 as against Tk. 2.84, Tk. 34.59, Tk. 23.95 and Tk. 0.18 respectively for the year ended December 31, 2023.
DHAKAINS: Price Limit Open03 Jun 2025
There will be no price limit on the trading of the shares of the Company today (03.06.2025) following its corporate declaration.
DHAKAINS: Q1 Financials03 Jun 2025
(Q1 Un-audited): EPS was Tk. 0.50 for January-March 2025 as against Tk. 0.75 for January-March 2024. NOCFPS was Tk. (0.66) for January-March 2025 as against Tk. 0.83 for January-March 2024. NAV per share (with revaluation) was Tk. 36.56 as on March 31, 2025 and Tk. 35.65 as on December 31, 2024, NAV per share (without revaluation) was Tk. 25.93 as on March 31, 2025 and Tk. 25.02 as on December 31, 2024. Reasons for deviation in EPS and NOCFPS: (cont.)
DHAKAINS: Reschedule of Board Meeting under LR 19(1)26 May 2025
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on June 02, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.
DHAKAINS: Board Meeting schedule under LR 16(1)26 May 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 02, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.
DHAKAINS: Postponement of Board Meeting schedule under LR 19(1)30 Apr 2025
The Company has further informed that due to unavoidable circumstances, the meeting scheduled to be held on April 30, 2025 at 3:00 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements of the Company for the year ended December 31, 2024, has been postponed. New date and time of the meeting will be notified later.
DHAKAINS: Board Meeting schedule under LR 19(1)22 Apr 2025
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.